Hospitals & Health Systems

Newsweek's 2026 list is more than a guide for parents; it's a window into the future of pediatric care. We break down the complex metrics.

Physicians are being warned about indemnification clauses in contracts that can shift immense liability. Here's what doctors need to know to avoid financial ruin.

Marking 10 years, Wellpoint Iowa's $5M+ investment in community programs reveals a strategic playbook for tackling the social drivers of health.

An announcement in Montreal signals a key public-private project between the federal government and developer SDA, likely targeting social infrastructure.

A landmark study reveals AI engines snub giants like Walmart and Marriott, favoring regional darlings. This is the new battleground for brand survival.

The market for T-cell malignancy treatments is set to surpass $1.8B, fueled by a pipeline of innovative drugs aiming to meet vast unmet patient needs.

A new study reveals patients trust AI algorithms over doctor recommendations, forcing a high-stakes reckoning for medical practices and patient safety alike.

As nursing shortages reach a crisis point, BayCare Health System is deploying a fleet of autonomous robots to handle logistics, freeing up staff for patient care.

The design giant unveils its vision at Fulton Market, blending AI tools, iconic updates, and a deep commitment to sustainability across work, home, and health.

Perspective Therapeutics is testing a potent alpha-particle therapy for meningioma, the most common brain tumor, offering a new option where surgery fails.

A new partnership aims to slash clinician onboarding times using AI, tackling a 7.2M patient backlog. But can technology solve a deeply human workforce crisis?

As corporate interests reshape medicine, a leading physician's call for stewardship revives a debate on the soul of healthcare. Can timeless values survive?

Intended to heal, some Physician Health Programs are accused of using flawed science and financial coercion to ruin careers. Are they a safety net or a trap?

A call for research on vaccine side effects exposes a deeper crisis: the collapse of public trust in science. Can rigorous data heal a polarized nation?

As Rise Therapeutics advances its oral drug R-2487, it’s not just developing another pill. It’s testing a radical new idea: resetting the immune system.

A burgeoning market for cervical dystonia is set for disruption. A pipeline of novel therapies, including oral options, promises to address unmet patient needs.

Penn Highlands Healthcare is offering up to $65K in loan repayment to build its workforce. Is this the new blueprint for solving talent shortages?

Beyond a single deal, LTC is trading its stable landlord model for a high-growth operator strategy, betting hundreds of millions on the future of senior care.

A breakthrough in cardiac fibrosis treatment reveals more than a new drug; it signals a systemic shift. How AI and human 'organoids' are making animal models obsolete.

While competitors build complex apps, Maxwell TEC is winning the home care market with simple SMS. Their milestone is a strategic signal for patient engagement.